|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Morgan Stanley on February 12, 2021. The analyst firm set a price target for 45.00 expecting PACB to rise to within 12 months (a possible 54.37% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $29.15 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Pacific Biosciences.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.